NMRA · Neumora Therapeutics, Inc. · Off Exchange
$0.33
-0.01 (-3.78%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q4 2025 earnings call transcript
Going-concern doubt
— flagged Nov 16, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, the Company has concluded that substantial doubt exists about its ability to continue as a going concern.”View the 10-Q filed Nov 16, 2026
Market Cap
$63.01M
Shares
188.69M
Volume · Nov 20
1.06M
Avg daily vol (3M)
1.67M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-10-12 | 1,998,866 | 7,514,564 | 9,513,430 | 61.4% |
| 2026-10-05 | 1,519,895 | 3,908,607 | 5,428,502 | 56.7% |
| 2026-09-28 | 3,867,088 | 4,103,485 | 7,970,573 | 63.8% |
| 2026-09-21 | 2,328,730 | 3,406,085 | 5,734,815 | 55.5% |
| 2026-09-14 | 3,385,861 | 3,710,284 | 7,096,145 | 56.8% |
| 2026-09-07 | 701,262 | 1,341,977 | 2,043,239 | 53.4% |
| 2026-08-31 | 436,429 | 602,780 | 1,039,209 | 39.5% |
| 2026-08-24 | 638,443 | 1,066,572 | 1,705,015 | 50.2% |
| 2026-08-17 | 939,603 | 661,894 | 1,601,497 | 33.1% |
| 2026-08-10 | 553,672 | 624,776 | 1,178,448 | 38.0% |
| 2026-08-03 | 569,682 | 568,620 | 1,138,302 | 39.1% |
| 2026-07-27 | 888,127 | 947,145 | 1,835,272 | 42.7% |
| 2026-07-20 | 550,335 | 388,732 | 939,067 | 38.4% |
| 2026-07-13 | 650,509 | 619,547 | 1,270,056 | 33.4% |
| 2026-07-06 | 1,113,705 | 1,040,413 | 2,154,118 | 34.3% |
| 2026-06-29 | 879,078 | 1,301,405 | 2,180,483 | 43.8% |
| 2026-06-22 | 2,374,535 | 4,044,442 | 6,418,977 | 29.6% |
| 2026-06-15 | 6,263,440 | 27,516,892 | 33,780,332 | 62.8% |
| 2026-06-08 | 706,022 | 932,146 | 1,638,168 | 41.7% |
| 2026-06-01 | 633,887 | 1,033,110 | 1,666,997 | 43.2% |
| 2026-05-25 | 630,334 | 1,014,272 | 1,644,606 | 39.3% |
| 2026-05-18 | 1,027,407 | 1,808,400 | 2,835,807 | 48.2% |
| 2026-05-11 | 932,346 | 2,373,994 | 3,306,340 | 52.6% |
| 2026-05-04 | 1,491,266 | 2,766,119 | 4,257,385 | 49.8% |
| 2026-04-27 | 2,245,759 | 2,572,917 | 4,818,676 | 54.1% |
| 2026-04-20 | 1,606,060 | 2,061,786 | 3,667,846 | 49.2% |
| 2026-04-13 | 1,498,300 | 1,921,462 | 3,419,762 | 54.9% |
| 2026-04-06 | 1,717,325 | 1,262,232 | 2,979,557 | 50.5% |
| 2026-03-30 | 2,003,966 | 1,999,964 | 4,003,930 | 45.5% |
| 2026-03-23 | 1,036,037 | 584,687 | 1,620,724 | 42.1% |
| 2026-03-16 | 592,354 | 1,022,475 | 1,614,829 | 48.2% |
| 2026-03-09 | 978,349 | 1,817,501 | 2,795,850 | 53.3% |
| 2026-03-02 | 782,073 | 1,230,593 | 2,012,666 | 40.2% |
| 2026-02-23 | 383,785 | 855,701 | 1,239,486 | 47.2% |
| 2026-02-16 | 813,441 | 1,664,034 | 2,477,475 | 42.4% |
| 2026-02-09 | 3,001,059 | 8,416,002 | 11,417,061 | 56.2% |
| 2026-02-02 | 657,734 | 1,017,685 | 1,675,419 | 46.6% |
| 2026-01-26 | 434,468 | 1,298,772 | 1,733,240 | 52.6% |
| 2026-01-19 | 472,531 | 1,666,177 | 2,138,708 | 50.4% |
| 2026-01-12 | 669,972 | 6,725,542 | 7,395,514 | 70.6% |
| 2026-01-05 | 3,773,921 | 11,853,089 | 15,627,010 | 56.0% |
| 2025-12-29 | 552,155 | 1,856,112 | 2,408,267 | 57.4% |
| 2025-12-22 | 665,581 | 1,551,118 | 2,216,699 | 55.8% |
| 2025-12-15 | 1,000,000 | 1,410,335 | 2,410,335 | 52.7% |
| 2025-12-08 | 550,812 | 1,113,746 | 1,664,558 | 52.9% |
| 2025-12-01 | 1,265,416 | 2,287,664 | 3,553,080 | 50.6% |
| 2025-11-24 | 858,762 | 2,001,043 | 2,859,805 | 64.4% |
Showing 1–47 of 47 weeks
Key facts
CIK
1885522
CUSIP
640979100
13F (30d)
143 filings
117 filers
Visit website
Investor relations